Clinical Trial

A Study of Enalapril in Treatment of Venous Malformations

Study acronym: EVA
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to explore if enalapril can be used to treat painful venous malformations. The main question it aims to answer are: \- Can enalapril reduce pain and volume of the malformation and increase quality of life in patients with painful venous malformations? Participants will: Receive a dose of enalapril 5 mg once daily. If it doesn't have effect the dose of enalapril will be increased to 10 mg daily after 3 months. The treatment duration will be 12 months, with an additional follow-up of 12 months. The visit frequency will be after 1, 3, 6,9 and 12 months and then a follow up visit at 18 and 24 months. Approximately 15 participants will be screened to achieve minimum 10 enrolled participants.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-01-16.
Status change: Not Yet Recruiting → Recruiting 2025-03-27
Trial Details
NCT Number NCT06788314
Lead Sponsor Oslo University Hospital
Conditions Venous Malformation, Pain, Quality of Life, Vascular Malformation
Enrollment 12 participants
Start Date 2025-02-01
Primary Completion 2029-12-01 (estimated)
Study Completion 2030-12-01 (estimated)
Updated on ClinicalTrials.gov 2025-04-02